Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors - Concepedia

Concepedia

Publication | Open Access

Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors

DOI Full Paper Access

54

Citations

27

References

2019

Year

Yasuhiro Kato, Yukio Hosomi, Kageaki Watanabe, Makiko Yomota, Shoko Kawai, Yusuke Okuma, Kaoru Kubota, Masahiro Seike, Akihiko Gemma, Tatsuru Okamura

Journal of Thoracic Disease

Abstract

Poor ECOG-PS and younger age were associated with lower efficacy of osimertinib in T790M-positive NSCLC.

References

	Year	Citations

Page 1